| Code | Description | Claims | Beneficiaries | Total Paid |
| 87428 |
|
10,886 |
5,411 |
$484K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
13,323 |
10,229 |
$380K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,336 |
1,585 |
$139K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,604 |
735 |
$138K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
13,144 |
6,026 |
$121K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
9,669 |
7,978 |
$118K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,840 |
6,418 |
$102K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
719 |
675 |
$10K |
| 99000 |
|
5,741 |
3,264 |
$8K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
231 |
218 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
140 |
137 |
$5K |
| 99072 |
|
6,216 |
4,950 |
$3K |
| 99441 |
|
132 |
101 |
$866.37 |